Regeneron Pharmaceuticals, Inc.

Farther Finance Advisors, LLC REGN

Report date

3/31/2026

Quarter

2026 Q1

Filed

4/7/2026

Shares

1,870

Value ($000)

1,454

Weight

0.0%

2022 Q4 - 2026 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	4/7/2026	1,454	0.0%	1,870	3/31/2026
2025 Q4	1/23/2026	1,538	0.0%	1,992	12/31/2025
2025 Q3	10/14/2025	832	0.0%	1,479	9/30/2025
2025 Q2	7/11/2025	331	0.0%	631	6/30/2025
2025 Q1	4/14/2025	387	0.0%	628	3/31/2025
2024 Q4	2/10/2025	409	0.0%	573	12/31/2024
2024 Q3	10/29/2024	761	0.0%	724	9/30/2024
2024 Q2	7/31/2024	710	0.0%	671	6/30/2024
2024 Q1	5/14/2024	621	0.0%	640	3/31/2024
2023 Q4	2/15/2024	558	0.0%	636	12/31/2023
2023 Q3	11/14/2023	401	0.1%	487	9/30/2023
2023 Q2	5/14/2024	213	0.0%	297	6/30/2023
2023 Q1	5/14/2024	89	0.0%	108	3/31/2023
2022 Q4	9/12/2023	76	0.0%	106	12/31/2022